OkpuaNCOkekpaSINjakaS,et al.Clinical diagnosis of prostate cancer using digital rectal examination and prostate-specific antigen tests: a systematic review and meta-analysis of sensitivity and specificity. Afr J Urol2021; 27: 32.
3.
Uroweb – European Association of Urology. EAU Guidelines. Edn. presented at the EAU Annual Congress Paris 2024. ISBN 978-94-92671-23-3, https://uroweb.org/guidelines/prostate-cancer (accessed 24 July 2024).
GohaganJKProrokPCHayesRB,et al.The prostate, lung, colorectal and ovarian (PLCO) cancer screening trial of the National Cancer Institute: History, organization, and status. Control Clin Trials2000; 21: 251S–272S.
7.
SchröderFHKrugerABRietbergenJ, et al.Evaluation of the digital rectal examination as a screening test for prostate cancer. JNCI J Natl Cancer Inst1998; 90: 1817–1823.
8.
AbdraboAAFadlallaAIFadl-ElmulaIM. Significance of serum total prostate specific antigen and digital rectal examination in the diagnosis of prostate cancer. Saudi Med J2011; 32: 1133–1136.
9.
TanWSWongAMahmaljiW,et al.Is there still a role for digital rectal examination in the prostate cancer diagnostic pathway in the COVID-19 and post COVID-19 era?Aging Male2021; 24: 92–94.
10.
García FigueredoIPereda-MeiraCMMorejón MoralesA, et al.The Cuban Institute of Oncology and Radiobiology experience on the beliefs and opinions about digital rectal exam in urological patients. Medwave2016; 16: e6501.
11.
GosselaarCRoobolMJRoemelingS,et al.The role of the digital rectal examination in subsequent screening visits in the European randomized study of screening for prostate cancer (ERSPC), Rotterdam. Eur Urol2008; 54: 581–588.
12.
SmithDSCatalonaWJ. Interexaminer variability of digital rectal examination in detecting prostate cancer. Urology1995; 45: 70–74.
13.
AhmedHUEl-Shater BosailyA, et al.Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): A paired validating confirmatory study. Lancet Lond Engl2017; 389: 815–822.
14.
de RooijMIsraëlBTummersM, et al.ESUR/ESUI consensus statements on multi-parametric MRI for the detection of clinically significant prostate cancer: Quality requirements for image acquisition, interpretation and radiologists’ training. Eur Radiol2020; 30: 5404–5416.
15.
KasivisvanathanVRannikkoASBorghiM, et al.MRI-targeted or standard biopsy for prostate-cancer diagnosis. N Engl J Med2018; 378: 1767–1777.
16.
JonesDFriendCDreherA, et al.The diagnostic test accuracy of rectal examination for prostate cancer diagnosis in symptomatic patients: A systematic review. BMC Fam Pract2018; 19: 79.
17.
MartinsMRegusciSRohnerS, et al.The diagnostic accuracy of multiparametric MRI for detection and localization of prostate cancer depends on the affected region. BJUI Compass2020; 2: 178–187.
18.
NgAKhetrapalPKasivisvanathanV. Is it PRIME time for biparametric magnetic resonance imaging in prostate cancer diagnosis?Eur Urol2022; 82: 1–2.
SajjadWThankappannairVShahS, et al.Diagnostic value of the abnormal digital rectal examination in the modern MRI-based prostate cancer diagnostic pathway. J Clin Urol2022. DOI: 10.1177/20514158221091402.